(Q57702534)
Statements
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial (English)
0 references
11 April 2007
0 references
18
0 references
5
0 references
1540-1546
0 references